Day: March 18, 2024

TORONTO, March 18, 2024 (GLOBE NEWSWIRE) — PTX Metals Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“PTX” or the “Company”) Board of Directors is pleased to welcome Jean David Moore to the Board and to appoint Felix Lee as Lead Director. M. Jean-David (“JD”) Moore brings an illustrious career spanning more than fifteen years of experience as a Canadian natural resources’ adviser and as a substantial investor in Canadian mining companies. JD currently serves Director positions at Fokus Mining Corp., Green Canada Corporation and most recently at Vanstar Mining Resources Inc., which was acquired by IAMGOLD Corp., in February 2024. JD Moore holds a master’s degree in forestry engineering from Laval University in Quebec, is a member of the Order of Forest Engineers of the Province of Quebec (OIFQ) and has, to date, published more...

Aspo Plc Press release March 18, 2024 at 15:45    Aspo’s subsidiary ESL Shipping to sell its Supramax vessels   Aspo Group’s subsidiary ESL Shipping has signed a memorandum of understanding according to which it will sell its two Supramax class vessels to companies belonging to HGF Denizcilik Limited Sirket group, a Turkish shipping and logistics company. The sale of the vessels is part of Aspo’s program announced in April 2023 to support and accelerate ESL Shipping’s low-carbon growth strategy.   The delivery of the vessels is expected to take place in April-May 2024. The sales price is USD 37.1 million and it is paid fully in cash. Considering the carrying amount of the vessels and the cost to sell, the sales loss is expected to be approximately EUR 7 million.   Following the sale of the Supramax vessels, ESL Shipping will continue to...

WALTHAM, Mass., March 18, 2024 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced the appointment of Amit Sharma, M.D., FACP, FASN, FNKF, to its Board as an independent, non-executive director, effective immediately. Dr. Sharma currently serves as Vice President of Clinical Development and Therapeutic Head for Nephrology and Hematology at Alexion, AstraZeneca Rare Disease, where he guides and executes the strategic direction of development products and programs within Alexion’s nephrology franchise across all stages of development. Prior to joining Alexion, he served as Vice President of Medical Affairs for the Cardiovascular and Renal Division of Bayer Pharmaceuticals. A widely recognized physician, Dr. Sharma has held numerous...

DURHAM, N.C., March 18, 2024 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results for the fourth quarter and year ended December 31, 2023, on Friday, March 22, 2024. Management will host a webcast and conference call at 8:00 a.m. ET to provide a corporate and financial update.Title: Humacyte Fourth Quarter and Year-End 2024 Earnings Conference CallDate: March 22, 2024Time 8:00 AM Eastern TimeConference Call Details 1-877-704-4453 (U.S. Investors Dial)1-201-389-0920 (International Investors Dial)13744046 (Conference ID)Call meTMFeature Click HereWebcast Webcast Link – Click HereThe webcast should be accessible 15 minutes prior to the conference...

BOSTON, March 18, 2024 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, announced today that it has entered into a subscription agreement to sell pre-funded warrants to purchase up to 1,032,702 shares of its common stock at a purchase price of $5.81 per pre-funded warrant in a private placement to GKCC, LLC. GKCC, LLC is an entity controlled by a member of Elicio’s Board of Directors. Each pre-funded warrant will be exercisable at any time on or after the closing date at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the pre-funded warrant, subject to a post-exercise beneficial ownership limitation of 19.99%, unless stockholder...

LAS VEGAS, March 18, 2024 (GLOBE NEWSWIRE) — Auto Parts 4 Less Group Inc. (OTC: FLES) (“AutoParts4Less,” “the Company”), a technology-driven e-commerce leader in the automotive parts sector, is pleased to announce another significant step in its ongoing efforts to improve its financial position. The Company has successfully converted $461,450k of debt into common stock, with a two-year lockup period, further demonstrating its commitment to cleaning up its balance sheet and moving forward. “This latest debt conversion is yet another win for our shareholders and all of our stakeholders,” said Christopher Davenport, CEO of Auto Parts 4 Less Group Inc. “Building on our previous efforts, including the conversion of nearly $1.2 million in debt announced on March 11, 2024, we continue to work...

MIAMI, March 18, 2024 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a “SKYX Technologies”), a highly disruptive platform technology company with over 77 pending and issued patents globally, and over 60 lighting and home décor websites with a mission to make homes and buildings become safe-advanced and smart as the new standard, announced today that management will participate in the 36th Annual ROTH Conference, which is being held March 17-19, 2024 in Dana Point, California. Founder and Executive Chairman Rani Kohen and Co-CEO Lenny Sokolow will host one-on-one and group meetings with institutional investors and analysts on Monday, March 18th and Tuesday, March 19th. For further details, invitation requests, or to arrange a one-on-one meeting, please email ononone@roth.com or reach out to your ROTH MKM...